Vol 11, No 5 (2022)
Date published: 2022-10-31
Table of Contents
open access
paid access
Saroglitazar: One Molecule for Managing Two Diseases, Type 2 Diabetes and Hypertriglyceridemia
Dhruvi Hasnani, Vipul Chavda
Editorial
Ayşe Gündüz, Süleyman Görpelioğlu, Canan Emiroğlu, Özlem Suvak, Cenk Aypak
Research paper
Vahid Shojaeimotlagh, Vajiheh Baghi, Pegah Dalvand, Yen-Fan Chin, Marzieh Aslani, Reza Ghanei Gheshlagh
Research paper
Arjun Baidya
Research paper
Rizal Fahly, Fabiola M.S. Adam, Haerani Rasyid, Andi Makbul Aman, Syakib Bakri, Idar Mappangara, Andi Alfian Zainuddin
Research paper
Survey to Specify SGLT2 Inhibitor Choice in T2DM Management
Samit Ghosal, Radhika M. Joshi, Rahul N. Iyer, Samir M. Adsule
Research paper
Canan Emiroğlu, Çağla Özdemir, Süleyman Görpelioğlu, Cenk Aypak
Research paper
Inpatient Mortality in People With Type 2 Diabetes: A Cross-sectional Study
Maria Cristina Carrondo, Joaquim Jorge Moita
Research paper
Impaired Brain Insulin Signalling,a Potential Cause of Obesity: A Review of Literature
Marta Bukowska
Review article
Prevalence of Cardiovascular Risk Factors in Type 1 Diabetes Mellitus Patients
Sameh Bougatf, Zohra Hadj Ali, Yosra Htira, Chaima Jemai, Imen Hedfi, Faika Ben Mami
Observation letter